Paluther, an anti-malarial drug developed by Chinese scientists in 1973, promises new hope to the millions suffering from the killer disease. On trial for the past 3 years in Tanzania and Kenya, the drug is expected to replace chloroquine and other anti-malarials in use in the 2 countries.
Shrikant Bhatt, who chairs the department of medicine in the University of Nairobi, says preliminary results show that Paluther is more effective than other anti-malarials. The growing resistance of certain malarial parasites to chloroquine has been disconcerting scientists across the world; Paluther's efficacy in building resistance to malaria and fighting malarial parasites as well will reassure them.
If introduced in the market, Paluther will join the SPF66, another anti-malarial vaccine developed by Columbian scientist Manuel Patarroyo, which is undergoing tests in Tanzania and Gambia.(IPS)
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.